Recital 28, Decision_act (EU) 2004/104

In forcesince 27 Nov 2002

During the procedure Aventis Pharma has been handling the contacts with the Commission on behalf of both Aventis Pharma SA and Rhône-Poulenc Biochimie SA. When "Aventis" is referred to in this Decision it is to be understood as Aventis Pharma acting on behalf of both themselves and RPB.

(b)

Merck